BCM
AMGN icon

Brooktree Capital Management’s Amgen AMGN Stock Holding History

Brooktree Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$362K Hold
1,000
– – 0.24% 37
2026
Q1 		$352K Hold
1,000
– – 0.28% 36
2025
Q4 		$327K Hold
1,000
– – 0.22% 33
2025
Q3 		$282K Hold
1,000
– – 0.18% 34
2025
Q2 		$279K Buy
+1,000
New +$283K 0.18% 34

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Brooktree Capital Management's AMGN Position: Q2 2026 in Review

Brooktree Capital Management held its Amgen (AMGN) position steady in Q2 2026 at 1,000 shares worth $362K. The position accounts for 0.24% of the portfolio, ranked #37.

Brooktree Capital Management first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Brooktree Capital Management held 1,000 shares of Amgen worth $362K as of Q2 2026.
  • Brooktree Capital Management left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.24% of Brooktree Capital Management's portfolio in Q2 2026, its #37 holding.
  • Brooktree Capital Management first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Brooktree Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.